Provided by Tiger Trade Technology Pte. Ltd.

Prime Medicine, Inc.

3.57
-0.0200-0.56%
Post-market: 3.54-0.0299-0.84%19:47 EDT
Volume:2.46M
Turnover:8.87M
Market Cap:644.42M
PE:-3.29
High:3.71
Open:3.54
Low:3.48
Close:3.59
52wk High:6.94
52wk Low:2.67
Shares:180.51M
Float Shares:116.00M
Volume Ratio:1.03
T/O Rate:2.12%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0853
EPS(LYR):-1.3521
ROE:-373.29%
ROA:-46.52%
PB:16.19
PE(LYR):-2.64

Loading ...

May 10, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 10, 2024

Major Issues Report

Form 8-K - Current report
Mar 01, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 01, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 01, 2024

Major Issues Report

Form 8-K - Current report
Feb 29, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 22, 2024

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
Feb 16, 2024

Major Issues Report

Form 8-K - Current report
Feb 15, 2024

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Feb 14, 2024

Major Issues Report

Form 8-K - Current report
Feb 09, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 08, 2024

Major Issues Report

Form 8-K - Current report
Jan 06, 2024

Major Issues Report

Form 8-K - Current report
Jan 05, 2024

Major Issues Report

Form 8-K - Current report
Nov 10, 2023

Correspondence

Form CORRESP - Correspondence
Nov 04, 2023

Major Issues Report

Form 8-K - Current report
Nov 03, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2023

Major Issues Report

Form 8-K - Current report
Aug 07, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 20, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities